Skip to content

Development of a Methodology to Design a High Order Sliding Mode Controller for Drug Dosage

Development of a Methodology to Design a High Order Sliding Mode Controller for Drug Dosage

Status
UNKNOWN
Phases
Unknown
Study type
Observational
Source
ClinicalTrials.gov
Registry ID
NCT02864212
Enrollment
30
Registered
2016-08-11
Start date
2014-09-30
Completion date
2021-12-31
Last updated
2020-08-06

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Anesthesia, Diabetes, Hypertension

Brief summary

The aim of this observational study is to create a data base to extract feature of fast-acting drugs that can be monitor in real time to design control strategies based on high order sliding mode controller to create a robust drug infusion system.

Detailed description

The aim of this observational study is to create a database to extract feature of fast-acting drugs that can be monitor in real time to design control strategies based on high order sliding mode controller to create a robust drug infusion system. The observed drugs in this study are fast acting insulin, propofol and sodium nitroprusside. The effect of insulin will be measured by a continuous glucose monitor, the effect of propofol by a bispectral index monitor and the the effect of sodium nitroprusside by a invasive blood pressure monitor.

Interventions

None listed

Sponsors

Coordinación de Investigación en Salud, Mexico
Lead SponsorOTHER_GOV

Study design

Observational model
CASE_ONLY
Time perspective
CROSS_SECTIONAL

Eligibility

Sex/Gender
ALL
Age
18 Years to 55 Years
Healthy volunteers
No

Inclusion criteria

* American Society of Anesthesiologists (ASA) physical status I, II, II

Exclusion criteria

* Impossibility to measure depth of anesthesia or invasive blood pressure. Impossibility of using glucose monitor.

Design outcomes

Primary

MeasureTime frameDescription
GlucoseEvery 5 minutes during 3 days.The glucose will be measured by a continuous glucose monitor. For the group of patients for diabetes. Note: This protocol has three primary outputs because its objective is to create a database of each output to analyze the response to the associated drug (insulin, propofol and sodium nitroprusside.
Bispectral IndexEvery second during surgeryDepth of anesthesia will be measured by a Bispectral Index monitor.
Invasive blood pressureEvery 5 minutes during surgery

Countries

Mexico

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026